Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...

The Chinese government took its economic sanctions against San Diego-based Illumina a step further Tuesday by banning the ...

Illumina is raising the curtain on its upcoming ... The company said its spatial technology will run on its current NextSeq and NovaSeq hardware through a new multimodal software platform, with ...

Illumina is not banned from operating in the country and will continue to serve its existing customers, a company ...

The Genomics Core offers a wide range of genomic and DNA/RNA services. We operate the Illumina NovaSeq X Plus, NextSeq 550, and MiSeq platforms for all Next Generation Sequencing and offer an ...

The other drivers for growth include Illumina’s core sequencing business, such as its NovaSeq X model, and complementing that with expansion into multiomics. Positioning the company toward ...

The combination of Illumina's Single Cell Prep, NovaSeq™ X Plus platform, 25B flow cell and DRAGEN™ analysis software creates a seamless end-to-end workflow enabling the high-throughput ...

Illumina Inc's NovaSeq X Plus gene sequencing system is shown in this undated handout photo obtained by Reuters ...

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a series of updates to its NovaSeq X Series, delivering the NovaSeq X single-flow ...

The spatial solution surpasses industry standards for scale and accuracy, and is compatible with Illumina NextSeq and NovaSeq sequencers, thereby materially reducing the cost of running large ...